Similar articles

• Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.

  Bubrick MP, Heim-Duthoy KL, Yellin AE, Berne TV, Heseltine PN, Appleman MD, Cocchetto DM, Matzke GR. Bubrick MP, et al. Am Surg. 1990 Oct;56(10):613-7. Am Surg. 1990. PMID: 2221611 Clinical Trial.
• A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.

  Joshi M, Fitzpatrick BJ, Warren JW, Caplan ES, Tenney JH. Joshi M, et al. Am Surg. 1986 Sep;52(9):467-71. Am Surg. 1986. PMID: 3530075 Clinical Trial.
• The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin.

  Poularas J, Giamarellou H, Vlachos G, Theakou R, Patoulis J, Lekakos N, Stavridis J, Sfikakis P. Poularas J, et al. Chemioterapia. 1988 Aug;7(4):253-5. Chemioterapia. 1988. PMID: 3180305 Clinical Trial.
• Current experience with clindamycin in the treatment of abdominal and female pelvic infections.

  Gorbach SL. Gorbach SL. Scand J Infect Dis Suppl. 1984;43:82-8. Scand J Infect Dis Suppl. 1984. PMID: 6398909 Review.
• Antibiotic therapy in intra-abdominal infections--a review on randomised clinical trials.

  Holzheimer RG, Dralle H. Holzheimer RG, et al. Eur J Med Res. 2001 Jul 30;6(7):277-91. Eur J Med Res. 2001. PMID: 11485888 Review.